衰老關(guān)鍵蛋白1(FBLN1)抗體對(duì)
Antibody Pair for Fibulin 1 (FBLN1)
- 編號(hào)PSC472Mu01
- 物種Mus musculus (Mouse，小鼠)相同的名稱，不同的物種。
- 試劑內(nèi)容
衰老關(guān)鍵蛋白1(FBLN1)重組蛋白 50ug 標(biāo)準(zhǔn)品 衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體 500ug 包被抗體 衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體(生物素標(biāo)記) 200ug 檢測(cè)抗體 - 應(yīng)用ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
- 下載英文說明書 中文說明書
- 規(guī)格96T*596T*1096T*2096T*5096T*100
- 價(jià)格¥ 6426¥ 10710¥ 19278¥ 37485¥ 64260
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
配對(duì)實(shí)驗(yàn)
用法
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月，-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPC472Mu01 | 衰老關(guān)鍵蛋白1(FBLN1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC472Mu01 | 衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體 | WB; IHC; ICC; IP. |
| LAC472Mu71 | 衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAC472Mu22 | 衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體 | WB; IHC; ICC; IP. |
| MAC472Mu21 | 衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體 | IHC; ICC/IF |
| LAC472Mu72 | 衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| SEC472Mu | 衰老關(guān)鍵蛋白1(FBLN1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMC472Mu | 衰老關(guān)鍵蛋白1(FBLN1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| PSC472Mu01 | 衰老關(guān)鍵蛋白1(FBLN1)抗體對(duì) | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| KSC472Mu01 | 衰老關(guān)鍵蛋白1(FBLN1)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Clin Exp Metastasis. | Augmented expression of urokinase plasminogen activator and extracellular matrix proteins associates with multiple myeloma progression[Pubmed:24807734] |
| Proteomics Clinical Applications | Comparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients[Pubmed:26680509] |
| PROTEOMICS?-?Clinical?Applications | Comparative mass spectrometric and immunoassay-based?proteome?analysis?in?serum?ofDuchenne muscular dystrophy?patients.[pubmed:26680509] |
| ENVIRONMENTAL RESEARCH | Exploration of identifying novel serum biomarkers for malignant mesothelioma using iTRAQ combined with 2D-LC-MS/MS[Pubmed: 33197421] |